Population pharmacokinetics of exendin‐(9‐39) and clinical dose selection in patients with congenital hyperinsulinism

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 84, Iss. 3, 2018-03 ,pp. : 520-532

John Wiley & Sons Inc

Access to resources Recommend Favorite

Profiles of biochemical parameters in central nervous system fluid during the therapeutic courses of adult Mycobacterium tuberculosis meningitis

By Erdem Hakan   Aksoy Bora   Kilic Selim   Yasar Avci Ismail   Pahsa Alaaddin   Polat Eyigun Can   Besirbellioglu Bulent   Yaman Halil  

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 8, 2006-08 ,pp. : 710-712

Informa Healthcare

Access to resources Recommend Favorite

Changes in the diagnosis of congenital cardiovascular malformations during the 1st year of life: impacts on epidemiological risk factor associations

By  

Cardiology in the Young, Vol. 27, Iss. 4, 2016-08 ,pp. : 770-781

Cambridge University Press

Access to resources Recommend Favorite

By  

JOURNAL OF PAEDIATRICS AND CHILD HEALTH, Vol. 51, Iss. 8, 2015-08 ,pp. : 826-829

John Wiley & Sons Inc

Access to resources Recommend Favorite

Congenital hyperinsulinism, neonatal diabetes and the risk of malignancies: an international collaborative study. Preliminary communication

By  

DIABETIC MEDICINE, Vol. 32, Iss. 5, 2015-05 ,pp. : 701-703

John Wiley & Sons Inc

Access to resources Recommend Favorite